
David Chung, The Visionary Behind Farmacy, The Rootist And ILabs, Talks Beauty Tariffs—And His Boldest Venture Yet
When Modere, a 23-year-old health and wellness MLM, abruptly shut down on April 11, 2025, it left thousands of direct-selling distributors without income or warning. It reignited age-old questions about the viability of multi-level marketing models, as the Utah company joined a domino line of similar companies—like Beautycounter, Seint, Rodan + Fields, Epicure,—that have recently shuttered or quick-pivoted to affiliate marketing.
Despite the fallout, serial beauty entrepreneur David Chung remains steadfast in his vision for Amare Global, a mental wellness and supplements company he acquired last year for an estimated $60 to $80 million.
'I wasn't actively looking to buy another company, but ... I looked into it and saw a lot of potential, despite the challenges.'
His goal: to redefine what direct selling can be in beauty and wellness.
'I'm always hungry to grow and make a difference—not just financially, but by bringing value to society,' says Chung, a philanthropist and advocate for Korean-American and AAPI communities.
Known for creating beloved brands like Farmacy Beauty and The Rootist, Chung is no stranger to innovation. With Amare Global, he sees an opportunity to essentially rebrand the MLM model—offering transparency, science-backed products, and a more sustainable path to income.
'My journey as an entrepreneur started from humble beginnings,' he reflects. David grew up in South Korea before moving to Queens, NY at age 11. His mother, Judith, opened a small cosmetics shop, which expanded into the Cici Korean Shopping Center. Chung witnessed how his mother's brick-and-mortar helped shape and build Koreatown in New York City.
In honor of her, Chung created the Judith Ehm Foundation to support public charities that help Korean-Americans, Asian-Americans, and the broader community with education, social services, and healthcare.
David Chung's mother, Judith Chungwon Ehm Chung, was one of the pioneers of Korea Town on 32nd Street in New York City, and a central figure in the Korean American community for decades.
'She passed on a mindset of perseverance and grit that still drives me today,' he says.
By the age of 25, Chung opened his first business, Nova Imports, and became a distributor for luxury Italian designer Emilio Pucci. He soon expanded into beauty, launching retail stores like Mona's in New Jersey and Cosmetic World in California, which sold luxury skincare brands like Dior and La Prairie. In 2003, he created his own high-tech skincare line, 3LAB, which became a top seller at Barneys New York.
To enhance product innovation, Chung founded Englewood Lab, a New Jersey-based R&D and manufacturing hub that served over 100 global brands, including L'Oréal and Clinique. In 2018, he sold a majority stake in Englewood Lab for $53.7 million, shifting focus to Farmacy, a clean skincare brand he had founded in 2015.
Farmacy pioneered a 'farm to face' philosophy, using responsibly sourced ingredients and bypassing raw material vendors to work directly with farmers. 'We had to remove 80% of the ingredients and replace them with cleaner, natural materials,' Chung said. 'We launched with Sephora and never looked back. And it ended with a beautiful exit.' The brand's star product, Green Clean Makeup Meltaway Cleansing Balm, became a cult favorite. The company's rapid rise led to a reported $350 million acquisition by Procter & Gamble in 2021, according to the Korea Economic Daily.
Building on that success, Chung in 2023 launched iLabs, a vertically integrated product development and manufacturing center in NJ serving both indie and global beauty brands. It offers R&D, formulations, and other turnkey contract manufacturing services for skin, body and hair brands. Its sprawling, state-of-the-art headquarters in New Jersey, employs his team of chemists, scientists and engineers. He later added Morae Packaging to offer sustainable packaging solutions. He then founded The Beauty Bank to incubate branding, digital marketing, PR and e-commerce operations for its brands. Today, Chung oversees nearly 1,000 employees across his portfolio of companies.
The Beauty Bank developed branding for The Rootist, a haircare line focused on scalp health and sustainability, which launched exclusively with Sephora North America in February 2024. Its ultra-concentrated formulas minimize water and packaging waste. 'Most shampoos and conditioners contain 70 to 90% water,' Chung explains. 'That means unnecessarily large bottles and excessive plastic waste are moving around the world to landfills.'
Chung's latest venture—his acquisition of Amare Global in January 2024—aims to leave a larger legacy. Founded in 2016 by Hiep Tran, Amare offers wellness supplements rooted in gut-brain axis research, a field that links gut health to emotional wellbeing. The challenge? Amare operates through a direct-sales model.
But Chung is undeterred. He believes Amare represents the future of wellness—and of direct selling itself. Here he discusses how his vertically integrated iLabs ecosystem paired with his philosophy of grit and giving back is the perfect formula for rebranding and restructuring Amare.
Before we discuss your latest venture, let's talk tariffs. How will the tariffs affect cosmetic manufacturing and packaging, and iLabs in particular?
China has been hit harder than any other country, and if these tariffs stick around or get worse, it could make it nearly impossible for us to continue sourcing materials from there. That's especially challenging when it comes to packaging materials for beauty products, which is where we're feeling the most impact.
This shift is opening new opportunities for iLabs. Luckily iLABs has manufacturing in both the U.S. and South Korea, which is a low tariff jurisdiction. Some of the skincare brands that used to manufacture abroad and ship to the U.S. are now reaching out to us to produce here instead.
From a formula perspective, our R&D expertise allows us to help our customers switch out raw materials from China to low-tariff countries.
We also have our own packaging company, Morae Packaging, so we directly manufacture glass and plastic components which avoids tariff uncertainty from China.
So, while the situation isn't easy, it's also pushing us—and our partners—to be more agile. It gives iLabs the opportunity to step up as a go-to partner for brands that want to manufacture closer to home, move faster, and reduce risk in a changing global market.
Let's move on to Amare. In a climate where MLMs are not welcomed with open arms, why did you choose to acquire Amare?
I wasn't actively looking to buy another company, but one of my employees introduced me to Amare, which was facing a financial crisis. I looked into it and saw a lot of potential, despite the challenges. The company was mismanaged—financially and strategically—and had made some costly mistakes with a previous acquisition. But I knew that with my resources, experience, and the companies I've built, like iLabs and Rootist, I could turn it around.
Within months of acquisition, we paid off debt and restructured operations.
What's next for Amare?
In 2025, Amare is on track for over $200 million in net sales. Our vision is to grow that to $1 billion within the next three years. We've already implemented key changes: a new management team and centralized operations for materials and manufacturing. Sales and marketing remain in Utah, but we're building operations in New Jersey.
This isn't just another direct selling company. We're reshaping the future of direct sales into what we call Next Generation Marketing. Traditional MLM models are outdated. People learn about products on Instagram, TikTok, and YouTube, and live shopping platforms. Our sellers should be able to educate, promote, and earn income in real time and from a direct website or social platform. Its future is affiliate-driven and transparent.
How does Amare address mental wellness issues?
This category is broad and urgent—people are dealing with stress, sleep disorders, focus issues, and more. Amare's products, like Happy Juice and our cognitive support supplements, are grounded in clinical research and proven efficacy.
But this business isn't just about supplements; it's a platform for total self-care: focus, sleep, emotional balance, and community. We currently have over 40,000 brand partners and around 50,000 active consumers. My goal is to equip our partners with the right tools—especially digital and video content—so they can educate others and share products authentically. Not every product is right for every person. Transparency matters.
What's your long-term vision for Amare?
There will be no private equity investors. I want to build something special without outsiders interfering with their quest for fast profits.
I don't need fast profits because I have built a sustainable ecosystem of beauty R&D and manufacturing operations. I tell my team: don't obsess over profit. Focus on relationships, service, and reputation. For example, if an iLabs manufacturing client can't pay full on time, we still deliver our best service. That's how you build long-term trust and a premium brand.
This is where many private equity firms fail. They look only at numbers and forget the people who made the business successful. That's how great companies like Beautycounter and Rodan+Fields have been damaged by private equity.
The Rootist Densify Collection
You are already known for Farmacy and The Rootist that have become bestsellers in Ulta and Sephora. Why take this risky move and acquire Amare?
Farmacy was born out of a vision for clean beauty. It aligned with an emerging generation of consumers who cared about sustainable ingredients, and the planet. But Amare gives me something deeper—a chance to build a business while helping others.
The Rootist was born from a similar idea—solving the root cause of hair issues with smart, waterless formulations. Why ship big bottles that are 80% water? We created compact, high-tech products and packages that actually deliver results. It's innovation with intention.
You've been a leader for Asian-American communities long before the pandemic spurred the AAPI empowerment movement.
After my mother passed away two years ago, I started Judith Ehm Foundation in her honor. It supports Korean-American communities and nonprofits globally. Amare also has its own nonprofit arm, Caring Hands, helping communities in Mexico, the Philippines, and beyond. Giving back is part of our DNA.
With Amare now part of your portfolio of companies, what is next for you as a serial beauty entrepreneur?
Keep evolving, keep innovating, and keep leading with purpose. I believe the next generation of beauty and wellness will be defined by authenticity, mental strength, and meaningful impact.
This is my dream. This is my legacy. And I'm just getting started.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Elon Musk Warns of Losing Tesla Control, Denies Personal Loans Tied To Shares
Elon Musk, the CEO of Tesla Inc. (NASDAQ:TSLA), has expressed concerns over potentially losing control of the electric vehicle giant due to the influence of activist shareholders. What Happened: Musk, who currently owns a 12.8% stake in Tesla, is apprehensive about being dethroned by shareholders who may not align with his vision for the company's future. He suggests that a 25% ownership stake would offer him adequate influence, while still leaving room for his possible removal. Musk's fears are rooted in past instances where shareholders voted in favor of a compensation package tied to the company's growth targets, only to be overruled by Delaware Chancery Court Judge Kathaleen McCormick. Earlier in January in a post on X, he shared that about 25 percent ownership stake would be enough "to be influential, but not so much that I can't be overturned.'Musk has the opportunity to acquire an additional 304 million shares, which would boost his voting control by roughly 4% post-tax. Also Read: Elon Musk Returns To Intense Work Schedule: 'Back To Working 7 Days a Week and Sleeping in the Office' In a recent statement on Friday on X, Musk affirmed that he has no personal loans against Tesla stock and reiterated his anxieties about being ousted by 'activist shareholders'. He expressed optimism that these concerns would be addressed at the forthcoming shareholders' are rumors that Musk may resign if his ownership stake is curtailed, akin to the limitations imposed on his pay package. Nonetheless, a majority of shareholders who endorsed Musk's pay package continue to support his leadership of Tesla's operations. Why It Matters: Musk's concerns highlight the potential power dynamics at play within Tesla's shareholder base. His potential loss of control could significantly impact the company's strategic direction, given his instrumental role in shaping Tesla's innovative trajectory. The upcoming shareholders' meeting will be a critical event, potentially determining the future of Musk's leadership at Tesla. Read Next Elon Musk Commits To Intense Focus on X/xAI and Tesla: 'Back To Spending 24/7 at Work, Sleeping in Conference/Server/Factory Rooms' Image: Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? TESLA (TSLA): Free Stock Analysis Report This article Elon Musk Warns of Losing Tesla Control, Denies Personal Loans Tied To Shares originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 minutes ago
- Yahoo
Food earmarked for millions of people still languishes in warehouses after Trump shuttered USAID
Food aid groups that partner with the U.S. Agency for International Development to assist in providing critical nutrition for millions around the world have had to watch cases of food go to waste as the Trump administration dismantled USAID. In Georgia, Mana Nutrition, a company that creates ready-to-use therapeutic food, is waiting for someone to pick up 400,000 cases of its nutritional supplement to be shipped worldwide. The food could help an estimated 60 million people, but chaos with USAID has disrupted coordination, the company told the Washington Post. The company is planning to destroy approximately 585 cases of its peanut paste this month because it became too dated to ship while waiting for a new government contract that never happened. The owner of Mana Nutrition told The Post that some of it could have been added to previous shipments, but wasn't. But other companies or organizations that have or had contracts with the government to supply aid have faced similar issues in recent months. In July, approximately 500 metric tons of food aid, specifically high-energy biscuits meant for children in Afghanistan and Pakistan, expired while being stored in warehouses in Dubai. While the administration assured people that the small percentage of food aid wasted would not impact future shipments, some have raised concerns about the pattern that has been highlighted due to the dismantling of USAID. Last month, the company Edesia Nutrition waited for someone to pick up more than 100,000 boxes of nutritional aid that had sat in a warehouse in Rhode Island. After sounding the alarm, the shipments were finally picked up only after a Rhode Island retailer teamed up with the company. In May, several people familiar with USAID told Reuters that more than 60,000 metric tons of food, sourced from American farmers and manufacturers, was set to expired in warehouses by July. That concerned enough people that the Office of Inspector General said it would open an investigation into food aid in warehouses. It's unclear if that aid was eventually shipped. The Trump administration has sought to axe USAID by revoking federal funding and firing most of its staff. President Donald Trump and his allies have characterized USAID as an unnecessary agency filled with 'waste, fraud, and abuse.' USAID, which was established in the 1960s, was one of the world's leading distributors of food and aid. Partnering with other companies, USAID provided humanitarian assistance, medical necessities, education, and more to people living in poverty, war-torn countries, and disaster-impacted communities. A spokesperson for the State Department told the Post that it is 'constantly assessing global humanitarian needs and expects to allocate additional resources to address those needs in line with U.S. interests.' More than 730 million people face malnutrition or hunger worldwide, according to the World Health Organization. The U.S. is the single largest donor of international food assistance. Food aid has been especially highlighted recently as people in Gaza are on the brink of starvation and face dire circumstances.
Yahoo
13 minutes ago
- Yahoo
Markel Group Inc. (MKL): A Bull Case Theory
We came across a bullish thesis on Markel Group Inc. on FluentinQuality's Substack. In this article, we will summarize the bulls' thesis on MKL. Markel Group Inc. 's share was trading at $2,008.29 as of July 31st. MKL's trailing and forward P/E were 12.05 and 15.04 respectively according to Yahoo Finance. An executive in a suit walking through an insurance office. Markel Group is a deliberately built, Berkshire-inspired holding company that quietly compounds value through a triad of specialty insurance, private businesses under Markel Ventures, and a long-term equity portfolio. Its strategy is rooted in consistency, optionality, and agility—not as abstract ideals, but as core design principles. The company's specialty insurance operations are deeply embedded in niche, hard-to-price markets with little competition, where switching providers is difficult due to the value derived from Markel's deep underwriting expertise. The underwriting culture prioritizes discipline and relationships over premium volume, resulting in consistent combined ratios below 100%. Markel Ventures complements this with wholly owned, cash-generative private businesses—often acquired from families—and operated autonomously. Meanwhile, the investment portfolio, skewed toward equities and influenced by Buffett-style principles, leverages insurance float for long-term gains. Capital allocation is opportunistic yet prudent, directed where long-term returns are highest. The decentralized structure empowers local leaders in both insurance and operating businesses, keeping decision-making close to the ground. Importantly, each of Markel's three flywheels—insurance, ventures, and investments—not only compounds independently but reinforces the others, creating an ecosystem of structural compounding. The company benefits from durable tailwinds such as rising specialty insurance demand, embedded pricing power, growing float leverage, and a long runway for small private acquisitions. Markel's conservative balance sheet, disciplined underwriting, and aversion to trend-chasing enable it to grow steadily without relying on leverage or market cycles. Designed for resilience and patient ownership, Markel continues to widen its moat quietly, compounding value by focusing where others don't—and letting time do the work. Previously we covered a bullish thesis on Markel Group Inc. (MKL) by Value Don't Lie in May 2025, which highlighted valuation upside, activist pressure, and improving capital allocation. The company's stock price has appreciated approximately by 10.7% since our coverage. The thesis still stands as underlying value remains underappreciated. FluentinQuality shares a similar thesis but emphasizes Markel's structural compounding design. Markel Group Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 41 hedge fund portfolios held MKL at the end of the first quarter which was 38 in the previous quarter. While we acknowledge the potential of MKL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None.